Document is current
Any future updates will be listed below
-
Authors
Coates, Laura C.
Bushmakin, Andrew G.
FitzGerald, Oliver
Gladman, Dafna D.
Fallon, Lara
Cappelleri, Joseph C.
Hsu, Ming-Ann
Helliwell, Philip S. https://orcid.org/0000-0002-4155-9105
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 24 November 2020
Accepted: 8 March 2021
First Online: 26 March 2021
Declarations
:
: Both primary studies were conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonisation Guidelines for Good Clinical Practice. All patients provided informed consent.
: Not applicable
: LCC is funded by a National Institute for Health Research (NIHR) Clinician Scientist award. The research was supported by the NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. LCC has also received honoraria and/or research funding from AbbVie, Amgen, Biogen, Celgene, Eli Lilly, Galapagos, Gilead, Janssen, Novartis, Pfizer Inc, and UCB. OF has received research grants from AbbVie, BMS, Eli Lilly, Novartis, and Pfizer Inc; is a consultant for BMS, Celgene, Eli Lilly, Janssen, and Pfizer Inc; and has been on speaker bureaus for AbbVie, Janssen, and Pfizer Inc. DDG has received research grants from AbbVie, Amgen, Celgene, Eli Lilly, Novartis, Pfizer Inc, and UCB, and is a consultant for AbbVie, Amgen, BMS, Celgene, Eli Lilly, Galapagos, Gilead, Janssen, Novartis, Pfizer Inc, and UCB. AGB, LF, JCC, and M-AH are stockholders and employees of Pfizer Inc. PSH has received research grants from AbbVie, Janssen, and Novartis, and is a consultant for AbbVie, Amgen, Celgene, Galapagos, Pfizer Inc, and UCB.
